Sino Biological Unveils AI-Certified Target Protein Collections for Drug Discovery

Sino Biological's Innovative Approach to AI-Driven Drug Discovery



In the rapidly evolving landscape of biotechnology, Sino Biological, Inc. has made significant strides by introducing two remarkable collections of target proteins specifically designed for AI-assisted drug discovery. As artificial intelligence (AI) continues to gain momentum in the biosciences, the availability of well-characterized proteins becomes critical for researchers aiming to validate AI-designed molecules effectively.

Understanding the New Target Protein Collections


Sino Biological's latest offerings, the AI-Trusted Proteins and AI-Qualified Proteins, bring together over 11,000 recombinant target proteins to aid in the exploration and development of therapeutic solutions. Let's delve deeper into what these collections entail:

1. AI-Trusted Proteins


This collection features proteins that have already been proven effective in AI-focused projects and have been recognized in various peer-reviewed publications. Currently, it contains more than 600 targeted proteins along with over 960 individual proteins. Comprehensive characterization data accompanies each protein, including various analytical methods such as:
  • - SPR (Surface Plasmon Resonance)
  • - BLI (Bio-Layer Interferometry)
  • - ELISA (Enzyme-Linked Immunosorbent Assay)
  • - Cell-based activity assays
  • - SEC-HPLC (Size Exclusion Chromatography-High-Performance Liquid Chromatography)
  • - SEC-MALS (Multi-Angle Light Scattering)

These diverse analytical techniques ensure that researchers obtain authentic and reliable data that can be crucial for their studies.

2. AI-Qualified Proteins


Developed for further validation in AI projects, AI-Qualified Proteins highlight experimentally characterized binding activities. This collection includes over 680 target molecules and more than 1,700 individual proteins, making it a vast repository for research teams. Notably, proteins in this category may come in specialized formats such as biotinylated proteins, enhancing their utility in AI-based research workflows.

The Strengths of Sino Biological's Offerings


The reliability and efficiency of Sino Biological's new protein collections stem from the 4S System — Scale, Scope, Speed, and Supply. This meticulously designed infrastructure ensures researchers that they can access a wide range of proteins and formats that support long-term, sustainable research programs.

Moreover, Sino Biological developed a comprehensive directory of therapeutic target molecules, covering 12 therapeutic areas and over 100 diseases. This unprecedented catalog allows researchers to search for pertinent target molecules by specific conditions or regions of interest.

Introducing 4RISE™ for Enhanced AI Validation


At the heart of the 4RISE™ AI Lab Validation Solution, which includes Sino Biological's target protein library, there is a focus on seamless integration of high-throughput protein expression, binding and affinity characterization, assessment of developmental capabilities, and functional validation. Each aspect is essential for moving AI-designed molecules from computational predictions to experimental verification.

According to Dr. Rob Burgess, Chief Business Officer of Sino Biological US, "AI-assisted discoveries rely on reliable experimental resources to evaluate designed molecules and inform subsequent research decisions." He further elaborates that by synergizing AI-Trusted and AI-Qualified proteins with the 4S System, they aim to furnish researchers with well-characterized target resources that not only guarantee extensive coverage but also offer consistent supply chains, thus accelerating AI-driven protein and antibody discoveries.

Conclusion


Sino Biological's innovative collections signify a transformative step toward enhancing AI-centric research and development. As the integration of artificial intelligence in therapeutic discovery expands, the importance of reliable, characterized protein resources cannot be overstated. The firm’s commitment to providing researchers with effective tools is poised to drive significant advancements in the biotechnology sphere, shaping the future of drug development.

For more information, visit Sino Biological.

Topics Consumer Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.